NSCLC

You have access
Gefitinib and Afatinib Treatment in an Advanced Non-small Cell Lung Cancer (NSCLC) Patient Undergoing Hemodialysis
MELISSA BERSANELLI, MARCELLO TISEO, FABRIZIO ARTIOLI, LEONARDO LUCCHI and ANDREA ARDIZZONI

Anticancer Research June 2014, 34 (6) 3185-3188;
You have access
Predictive Role of CEA and CYFRA 21-1 in Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, MAREK MINARIK, ZBYNEK BORTLICEK and ONDREJ TOPOLCAN

Anticancer Research June 2014, 34 (6) 3205-3210;
You have access
Pertuzumab: Development Beyond Breast Cancer
PHILIPPE BARTHÉLÉMY, JULIE LEBLANC, VERONICA GOLDBARG, FRÉDÉRIQUE WENDLING and JEAN-EMMANUEL KURTZ

Anticancer Research April 2014, 34 (4) 1483-1491;
You have access
The Prognostic Significance of Eukaryotic Elongation Factor 1 Alpha-2 in Non-Small Cell Lung Cancer
MASAKI KAWAMURA, CHIAKI ENDO, AKIRA SAKURADA, FUMIHIKO HOSHI, HIROTSUGU NOTSUDA and TAKASHI KONDO

Anticancer Research February 2014, 34 (2) 651-658;
You have access
The Significance of HSP90AA1, HSP90AB1 and HSP90B1 Gene Polymorphisms in a Turkish Population with Non-small Cell Lung Cancer
ENDER COSKUNPINAR, NERGIZ AKKAYA, PINAR YILDIZ, YASEMIN MUSTERI OLTULU, ENGIN AYNACI, TURGAY ISBIR and ILHAN YAYLIM

Anticancer Research February 2014, 34 (2) 753-757;
You have access
Complete Metabolic Remission with Gefitinib in a Hemodialysis Patient with Bone Metastases from Non-small Cell Lung Cancer
ALESSANDRO DEL CONTE, EMILIO MINATEL, DOMENICO SCHINELLA, TANJA BARESIC, STEFANO M.M. BASSO and FRANCO LUMACHI

Anticancer Research January 2014, 34 (1) 319-322;
You have access
High-throughput Molecular Genotyping for Small Biopsy Samples in Advanced Non-small Cell Lung Cancer Patients
CHI HOON MAENG, HO YUN LEE, YOUNG WOOK KIM, MOON KI CHOI, JUNG YONG HONG, HYUN AE JUNG, KYUNG SOO LEE, HOJOONG KIM, O JUNG KWON, JONG-MU SUN, JIN SEOK AHN, KEUNCHIL PARK, SANG-WON UM and MYUNG-JU AHN

Anticancer Research November 2013, 33 (11) 5127-5133;
You have access
Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
DORTE SCHOU NØRØXE, SANDRA WALLEREK and JENS BENN SØRENSEN

Anticancer Research August 2013, 33 (8) 3275-3278;
You have access
Sequential Treatment of Advanced-stage Lung Adenocarcinoma Harboring Wild-type EGFR Gene: Second-line Pemetrexed Followed by Third-line Erlotinib versus the Reverse Sequence
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, ZBYNEK BORTLICEK and MAREK MINARIK

Anticancer Research August 2013, 33 (8) 3397-3402;
You have access
Carboxy-terminal Telopeptide (CTX) and Amino-terminal Propeptide (PINP) of Type I Collagen as Markers of Bone Metastases in Patients with Non-small Cell Lung Cancer
FRANCO LUMACHI, DAVIDE A. SANTEUFEMIA, ALESSANDRO DEL CONTE, FRANCESCO MAZZA, RENATO TOZZOLI, GIORDANO B. CHIARA and STEFANO M. M. BASSO

Anticancer Research June 2013, 33 (6) 2593-2596;

Main menu

User menu

Search

NSCLC

Pages